ESC - European Society of Cardiology
ESC - European Society of Cardiology
09/01/2024 | Press release | Distributed by Public on 09/01/2024 04:15
Finerenone improves outcomes in a common type of heart failure
Notes to editor
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2024. It does not necessarily reflect the opinion of the European Society of Cardiology.
ESC Press Office
Tel: +33 (0)6 61 40 18 84
Email: [email protected]
The hashtag for ESC Congress 2024 is #ESCCongress
Follow us on X @ESCardioNews
Journalists are invited to become accredited and register here.
Check out the ESC Media and Embargo Policy.
Funding: The FINEARTS-HF trial was sponsored by Bayer.
Disclosures: Scott Solomon reports receiving research grants from Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/Bridgebio, Gossamer, GSK, Ionis, Lilly, NIH/NHLBI, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI and has consulted for Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros and Valo.
References and notes
1'FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction' will be discussed during Hot Line 7 on Sunday 1 September in room London.
2McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2024;26:5-17.
It is the world's largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in London and online - from 30 August to 2 September. Explore the scientific programme. More information is available from the ESC Press Office at [email protected].
About the European Society of Cardiology
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.
ESC - European Society of Cardiology published this content on September 01, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 01, 2024 at 10:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]